Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Nine Clinical Cases Report
Overview
Overview
Journal
J Clin Endocrinol Metab
Publisher
Oxford University Press
Specialty
Endocrinology
Date
2017 Mar 31
PMID
28359104
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature.
Tay W, Tay D Endocrinol Metab (Seoul). 2022; 37(2):183-194.
PMID: 35417954 PMC: 9081316. DOI: 10.3803/EnM.2021.1369.